This Stock Soared 9,800% in 2025. Here's 1 Key Reason Why Investors Are Piling In (Spoiler: It's Regencell Bioscience Holdings (RGC) Stock)

Group 1 - Regencell Bioscience Holdings has experienced a significant increase in share price, surging 9,800% year to date as of November 19, 2023 [1] - The company focuses on the research, development, and commercialization of Traditional Chinese Medicine for neurocognitive disorders, specifically ADHD and Autism Spectrum Disorder [2] - Despite its exciting mission, Regencell has reported $0 in revenue for the years 2021 through 2025, indicating ongoing financial losses [2][4] Group 2 - The company executed a 38-for-1 stock split in June 2023 after a dramatic price increase of approximately 60,000%, which may have created a misleading sense of value among investors [4] - Regencell's market capitalization recently topped $6 billion, raising concerns about its valuation given the lack of commercial products [4][7] - Analysts suggest that there are better investment opportunities available, as Regencell appears to be a risky bet with no revenue generation for several consecutive years [6][7]